VolitionRx Limited Announces Third Quarter 2021 Financial Results and Business UpdatePRNewsWire • 11/10/21
VolitionRx Limited Schedules Third Quarter 2021 Earnings Conference Call and Business UpdatePRNewsWire • 11/08/21
Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society ConferencePRNewsWire • 11/04/21
VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business UpdatePRNewsWire • 08/11/21
VolitionRx Limited Schedules Second Quarter 2021 Earnings Conference Call and Business UpdatePRNewsWire • 08/04/21
Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease MonitoringPRNewsWire • 07/22/21
VolitionRx Limited Announces First Quarter 2021 Financial Results and Business UpdatePRNewsWire • 05/11/21
VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business UpdatePRNewsWire • 05/06/21
VolitionRx Limited Announces Publication of Significant Nu.Q® Capture Mass Spectrometry PaperPRNewsWire • 03/31/21
VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for Volition Veterinary SubsidiaryPRNewsWire • 03/30/21
VolitionRx Limited Announces Full Fiscal Year 2020 Financial Results and Business UpdatePRNewsWire • 03/22/21
VolitionRx Limited Schedules Full Fiscal Year 2020 Earnings Conference Call and Business UpdatePRNewsWire • 03/16/21
Volition Has Released A Screening Test To Help Detect Early Stages Of Cancer In DogsBenzinga • 12/04/20
Cotterford Co. Ltd. Sends Letter to VolitionRX Following Annual Meeting Vote Results Confirming Deep-Seated Discontent Among ShareholdersBusiness Wire • 07/09/20
VolitionRx Limited's (VNRX) CEO Cameron Reynolds on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/13/19
VolitionRX Limited (VNRX) CEO Cameron Reynolds on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/13/19
VolitionRX Ltd. (VNRX) CEO Cameron Reynolds on Q4 2018 Results - Earnings Call TranscriptSeeking Alpha • 03/14/19